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Introduction
Congenital cystic adenomatoid malformation (CCAM) is one of the major congenital pulmonary 
anomalies.1-4 With the advent of antenatal ultrasonography (USG), it was increasingly diagnosed 
as was its in-utero regression.5-7 Antenatal USG provides important information about the natural 
course of the condition and is pivotal in antenatal counselling and peri-natal management. 
However, the accuracy of findings from antenatal USG and postnatal chest radiographs (CXRs) 
have been questioned.8-12 We review the management and outcome of a cohort of cases with 
 Objective To review the management and outcome of babies with antenatally 
diagnosed congenital cystic adenomatoid malformation.
 Design Retrospective cohort review.
 Setting Tertiary neonatal care unit at Queen Mary Hospital and antenatal 
diagnostic centre at Tsan Yuk Hospital.
 Patients Consecutive patients with antenatally suspected congenital cystic 
adenomatoid malformation in their concepti among antenatal 
patients attending Tsan Yuk Hospital from 1994 to 2002. Twenty-
four of 33 cases were referred to Queen Mary Hospital for postnatal 
management and for whom comprehensive records were available 
for analysis in 23.
 Interventions Postnatal interventions in their babies included investigational 
imaging for congenital cystic adenomatoid malformation and 
surgery.
 Main outcome measures Antenatal and postnatal outcome, as well as pathology of the 
excised lesions.
 Results Antenatal outcome: termination of pregnancy in two cases and 
spontaneous abortion in one; in-utero regression was documented 
in nine cases and in one hydropic change was apparent. Postnatal 
outcome: only eight of 20 babies born alive had symptoms in 
neonatal period. Two developed serious infective complications 
in infancy, one with documented in-utero regression. Pulmonary 
parenchymal abnormalities were detected on computed tomography
  of the thorax in six of seven cases with normal or non-specific chest 
radiograph findings. Among nine cases with in-utero regression, 
congenital cystic adenomatoid malformation was confirmed by 
operative histology in five and abnormal computed tomography 
findings in three. Fifteen babies underwent surgical excision, 
one of whom died because of severe pre-existing pulmonary 
hypoplasia and nine endured minor postoperative complications. 
A favourable outcome was documented at a mean follow-up of 22 
months (range, 2 months-7 years).
 Conclusions In-utero regression of congenital cystic adenomatoid malformation 
on antenatal ultrasound may not represent genuine resolution. 
Computed tomographic thorax should be considered in all
  newborns with antenatally diagnosed congenital cystic adenomatoid
  malformation, and if confirmed early operation before first hospital 
discharge is recommended.
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antenatally diagnosed CCAM to verify the true incidence 
of in-utero regression, ascertain the best modality of 
postnatal imaging and the optimal timing of surgery.
Methods
The records of 33 consecutive mothers referred to 
the antenatal diagnostic centre at Tsan Yuk Hospital 
between 1994 and 2002 with concepti suspected to 
have CCAM were retrieved. Twenty-four were referred 
to Queen Mary Hospital for subsequent management, 
23 of whom had comprehensive records available for 
analysis; data pertaining to the nine remaining patients 
managed in other hospitals were not available. Antenatal 
USG was performed by experienced obstetricians using 
Acuson Sequoia or Acuson XP 128 (Mountain View, CA, 
US). Congenital cystic adenomatoid malformation was 
classified according to Adzick’s classification, based on 
sonographic features.13 Antenatal clinical information 
retrieved included the timing of the first and subsequent 
USG, the sonographic appearance of the lesions, presence 
or absence of polyhydramnios, mediastinal shift and 
hydrops and all antenatal interventions. Clinical data of 
babies born alive (sex, birth weight, gestational age, mode 
of delivery, Apgar scores, clinical presentation at birth) as 
well as postnatal imaging results including CXR and/or 
computed tomography (CT) of the thorax, and the type 
of surgery and age at that time were recorded. Pathology 
of the excised lesions, cases involving termination of 
pregnancy (TOP), spontaneous abortion, or neonatal 
death were also recorded if available. Histological types 
of the lesions were classified according to Stocker’s 
classification.14 Surviving cases were followed up at 
Queen Mary Hospital for a mean period of 22 months 
(range, 2 months-7 years). Growth parameters and 
respiratory symptoms were documented. The association 
between categorical variables was assessed by the Chi 
squared test. Ethical approval was not required as this 
was a retrospective descriptive review of clinical findings 
and all patients’ identities were kept confidential.
Results
Twenty-three cases with complete data were included in 
the analysis (Fig).
Antenatal ultrasound and progress
The diagnosis of CCAM was made at a mean of 21 weeks 
of gestation (range, 15-33 weeks); nine (39%) of 23 were 
detected during routine scans for anomalies. Lesions 
were noted in the left lung in 12 (52%) cases and in the 
right lung in 11 cases. Macrocystic lesions were noted in 
seven (30%) of the cases, all in the right lung. In contrast, 
all six (26%) cases with microcystic lesions were found 
in the left lung, five of which involved the lower lobe. 
The remaining 10 cases were classified as mixed type. 
Two mothers had TOP and one a spontaneous abortion. 
In the remaining 20 mothers, in-utero regression of the 
lesions was documented in nine (45%) cases; at 27 to 
33 weeks of gestation, six appeared to have complete 
regression and three partial regression. One (case 11) 
progressed with mediastinal shift and hydropic changes. 
Repeated amnio-reduction was performed and a cysto-
amniotic shunt was inserted at 28 weeks of gestation. 
The baby was delivered prematurely at 33 weeks of 
gestation. In-utero regression was noted in seven of 10 
cases affecting the left lung and two of eight with lesions 
in the right lung (P=0.07) but there was no association 
between the types of lesions and in-utero regression 
(P=0.2) [Table 1].
Postnatal imaging results
Postnatal CXRs were available in 19 of the 20 live births. 
Findings were normal or non-specific in seven babies. 
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Abnormal findings included cystic lesions in eight 
babies (five in the right and three in the left lung), ill-
defined opacities in three, and hyperlucency in one. 
Mediastinal shift was present in five babies. One baby 
(case 7) did not have a postnatal CXR as complete in-
utero regression was documented on antenatal USG and 
he was asymptomatic at birth. Computed tomography of 
the thorax was performed in all except one baby (case 
10) who underwent emergency surgery. Twelve cases 
(cases 2, 3, 6, 9, 13, 15, 17, 18, 20, 21, 22, 23) had CT 
thorax performed before their first hospital discharge. All 
revealed abnormalities in lung parenchyma, including 
multicystic lesions in nine babies, focal emphysematous 
change in one and hyperdense lesions in another. Chest 
X-ray at birth was normal or non-specific in three of these 
12 babies. Computed tomography of the thorax in case 7 
presenting as severe pneumonia at 5 months old, showed 
multicystic lesions with fluid levels suggestive of abscess 
formation and pleural effusion. In case 14, who had 
transient neonatal tachypnoea, his CXR at birth showed 
cystic lesions in the right side, but was discharged after 
a few days when his respiratory distress resolved. While 
waiting for an elective CT thorax at home, he developed 
a serious chest infection and cardiopulmonary arrest on 
day 12 of life. Computed tomographic thorax revealed 
multicystic lesions with fluid levels compatible with 
abscess formation secondary to CCAM. Cases 5, 8, 11, 12, 
and 16 were asymptomatic at birth. Chest X-ray of case 
8 showed cystic lesions in the right lung with no mass 
effect while the CXRs of the others were unremarkable. 
Computed tomographic thorax performed subsequently 
(after discharge) revealed multicystic lesions in two 
(cases 5, 8), a small subpleural wedge density in the 
right lower lobe in one (case 12), focal emphysema in 
Operation before 
first discharge (n=8; 
cases 3, 6, 10, 17, 20, 
21, 22, 23)
* CT denotes computed tomography of the thorax
FIG. Management flowchart of antenatally diagnosed congenital cystic adenomatoid malformation (CCAM)
Postnatal CT before first 
discharge (n=12; case 10 was 
unstable for CT)
Postnatal chest X-ray 
before first discharge 
(n=19)
Live birth (n=20)
Antenatal diagnosis of 
CCAM (n=23)
Operation not done 
(n=2; cases 15, 18)
Readmitted for
operation (n=3; cases 
2, 9, 13)
Operation before 
discharge (n=2; cases 
8, 14)
Readmitted for
operation (n=1; case 5)
Operation not done 
(n=3; cases 11, 12, 16)
Discharged after chest X-ray and 
readmitted later for CT (n=6; cases 
5, 8, 11, 12, 14, 16)
Readmitted for CT*, followed by 
operation (n=1; case 7)
Termination of pregnancy (n=2; cases 1, 4); 
missed abortion (n=1; case 19)
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left lower lobe in another (case 16), and a high-seating 
left diaphragm in the remaining baby (case 11). Real-
time ultrasound later confirmed the diagnosis of a left 
diaphragmatic hump (Table 2).
Postnatal symptoms, clinical course and 
management
All except three babies were born at term (range 33 
to 40 weeks of gestation). Twelve were male and eight 
were female. Eight babies (cases 3, 6, 10, 13, 14, 20, 
21, 22) developed respiratory symptoms at birth but 
there was no particular association with the type of 
antenatally diagnosed lesions (P=0.27). The baby with 
hydropic changes (case 10) required active resuscitation 
at birth and emergency lobectomy. The postnatal course 
of case 14 was described above. His lobectomy was 
performed after CT thorax demonstrated multicystic 
lesions with abscess formation. The remaining six 
symptomatic cases underwent surgery before discharge 
when CT thorax suggested CCAM. Twelve babies were 
asymptomatic at birth. The diagnosis of CCAM was made 
at the age of 5 months in case 7, when he presented 
as a chest infection. Lobectomy was performed at 1 
month later. Six asymptomatic babies (cases 2, 5, 7, 8, 
9, 17) underwent lobectomy at the age of 22 days to 20 
months. Conservative management was adopted in the 
remaining five (cases 11, 12, 15, 16, 18) in whom CT 
findings were not suggestive of CCAM. Pathology of the 
resected specimens showed CCAM in all 15 cases that 
had an operation; eight (53%) cases had type I and seven 
had type II. Congenital cystic adenomatoid malformation 
type I appeared to be more prevalent in right-sided lesions 
(6/8 cases), while on the left side 4/7 had type II, but this 
difference did not reach statistical significance (P=0.31). 
Postoperative complications were noted in nine babies, 
which included pneumothoraces (6 cases), segmental 
collapse of the lung (2 cases), chylothorax (1 case) and 
right phrenic nerve palsy (1 case). All recovered with 
conservative management. One patent (case 10) died 
postoperatively due to severe pre-existing pulmonary 
hypoplasia (Tables 3, 4).
* CCAM denotes congenital cystic adenomatoid malformation, L left lung, R right lung, LWL left whole lung, and LLL left lower lobe
† Abnormality detected during routine anomaly scan
Case 
No.
Year of 
birth
Gestational age 
at diagnosis 
(weeks)
CCAM
location*
CCAM appearance Mediastinal 
shift
CCAM progress
1 1994 18† L Mixed Yes Termination of pregnancy
2 1995 26 L Mixed Resolved Regressed, no shift
3 1995 33 R Macrocystic Yes Static
4 1995 19† R Macrocystic Yes Termination of pregnancy
5 1996 23 R Mixed No Static
6 1996 16 LWL Microcysitc (echogenic) Yes Static
7 1997 19† R Mixed Resolved Regressed, no shift at 30 weeks
8 1998 18 R Mixed Yes Static
9 1998 18 R Macrocystic Yes Static
10 1998 24 R Macrocystic Yes Hydropic change and polyhydramnios. 
Repeated amnio-reduction, cyst-amniotic 
shunt at 28 weeks
11 1998 32 L Mixed No Regressed
12 1999 15 R Macrocystic No Regressed at 27 weeks
13 1999 22 R Macrocystic Yes Static
14 2000 32 R Macrocystic Yes Static
15 2000 20† LLL Microcystic (echogenic) No Regressed at 32 weeks
16 2000 21† LLL Microcystic (echogenic) Resolved Regressed, no shift at 28 weeks
17 2001 18† LLL Microcystic (echogenic) Resolved Regressed, no shift at 33 weeks
18 2001 20 LLL Microcystic (echogenic) Yes Static
19 2001 18 L Mixed Yes Missed abortion
20 2002 20† L Mixed Resolved Regressed, no shift at 33 weeks
21 2002 23† L Mixed No Static
22 2002 22† LLL Microcystic (echogenic) Yes Regressed
23 2002 18 R Mixed Yes Static
TABLE 1.  Antenatal ultrasonography findings
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Case 
No.
Chest X-ray at birth Computed tomography findings CCAM pathology
Appearance Location Shift Appearance Location* Shift Overall Location*
2 Cystic Left Yes Multicystic LLL Yes I LLL
3 Cystic Right Yes Multicystic RLL Yes I RLL
5 Alveolar shadow Right No Multicystic RLL No II RLL
6 Cystic Left Yes Multicystic LUL, LLL No II LUL
7 N/A† N/A No Multicystic with abscess RLL Yes I RLL
8 Cystic Right No Multicystic RLL Yes II RLL
9 Ill-defined shadow - No Multicystic RUL No I RUL
10 Cystic Right Yes N/A N/A N/A I RUL
11 Non-specific - No Left diaphragmatic hump N/A No N/A N/A
12 Normal - No Wedge density RLL No N/A N/A
13 Cystic Right Yes Multicystic RLL, ML Yes I RLL
14 Cystic Right No Multicystic with abscess RUL, ML Yes I RUL
15 Hyperlucency Left No Focal emphysema LLL No N/A N/A
16 Normal - No Focal emphysema LLL No N/A N/A
17 Cystic Left No Multicystic LLL No II LLL
18 Normal - No Focal emphysema LLL No N/A N/A
20 Opacity Left No Multicystic LLL No II LLL
21 Opacity Left No Tissue density LLL No I LLL
22 Normal - No Multicystic LLL No II LLL
23 Opacity Right No Multiple microcystic RUL, RML No II RUL, RML
TABLE 2. Postnatal imaging and pathology of congenital cystic adenomatoid malformation (CCAM)
* LLL denotes left lower lobe, RLL right lower lobe, LUL left upper lobe, RUL right upper lobe, and ML middle lobe 
† N/A denotes not applicable or not available
Case 
No.
Sex Symptoms at birth* Operation Follow-up
Type Age Postoperative complications Period Outcome
3 F Mild RD at birth Lobectomy Day 3 Pneumothorax 7 years Well
6 M Mild RD, NCPAP at 
hour 6
Lobectomy Day 5 - 2 years Bell’s palsy at 
year 2
10 F Respiratory failure, 
hydrops
Lobectomy Day 1 Pneumothorax, haemothorax N/A† Died
13 M RD, fever at day 2 Lobectomy Day 23 Right upper lobe collapse 2 months Default at 
month 2
14 M TTNB resolved at day 2, 
pneumonia and arrest at 
day 12
Lobectomy Day 15 No 3 years Mild hypotonia
20 M Pneumonia Lobectomy Day 15 Left upper lobe segmental 
collapse
12 months Well
21 M RD, pneumothorax, IMV Segmental resection Day 35 Pneumothorax 11 months Residual cyst
22 F RD, sepsis, IMV at hour 10 Lobectomy Day 25 No 10 months Well
TABLE 3. Postnatal management and outcome of cases with symptoms at birth
* RD denotes respiratory distress, NCPAP nasal continuous positive airway pressure, TTNB transient tachypnoea of newborn, and IMV intermittent 
mandatory ventilation
† N/A denotes not applicable
Longer-term outcome
The 19 surviving babies were followed up for 2 months 
to 7 years (mean, 22 months). One (case 21) showed 
mild growth retardation. Two (cases 5 and 9) have 
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mild infrequent episodic asthma. One (case 23) had a 
suspected residual cyst noted on a follow-up CT scan, 
but clinically the patient was asymptomatic. The baby 
who was resuscitated from cardiopulmonary arrest on 
the 12th day of life was found to have mild hypotonia, 
but otherwise showed normal development. One baby 
(case 6) suffered a Bell’s palsy at 2 years of age (Tables 
3, 4).
Discussion
Congenital cystic adenomatoid malformation was first 
described by Ch’in and Tang in 1949.2 It is thought to 
be due to overgrowth of terminal bronchioles with 
suppression of alveolar development ensuing between 
5 and 8 weeks of gestation,1 with an incidence of one 
in 25 000 to 35 000 pregnancies.15,16 With advances in 
antenatal USG, CCAM has been increasingly diagnosed. 
During the study period, the antenatal diagnostic centre 
was the only tertiary referral centre for prenatal diagnosis 
and management of various congenital malformations in 
Hong Kong and there were 33 referrals. The incidence 
during this period was estimated to be 1:31 000 live 
births in 1996 to 1:16 000 live births in 2002.
 The gestational age at diagnosis was similar to that 
reported in other series. Left-sided lesions and lower lobe 
involvement were more common in previous studies2,14 
but the two sides were equally involved in the babies 
born alive in our cohort. In our study, lesions were more 
Case 
No.
Sex Subsequent symptoms 
or complications
Operation Follow-up
Type Age Postoperative complications Period Outcome
2 F Well Lobectomy Month 20 No 21 months Well
5 M Well Lobectomy Month 8 No 5.5 years Mild infrequent 
episodic 
asthma
7 M Right lung abscess at 
month 5
Lobectomy Month 6 Pleural effusion,
pneumothorax
- Well
8 M Well Lobectomy Day 29 Pneumothorax, chylothorax 6 months Well
9 M Well Lobectomy Day 40 Pneumothorax 4.5 years Infrequent
episodic 
asthma
11 M Well No N/A* N/A 3 months Well, closed at 
month 3
12 F Well No N/A N/A 2.8 years Well
15 M Well No N/A N/A 2.4 years Well
16 F Well No N/A N/A 2.3 years Well
17 F Heart failure due to
patent ductus arteriosus
Lobectomy, patent 
ductus arteriosus, 
ligation
Day 22 No 2 years Slow growth
18 M Well No N/A N/A 17 months Well
23 F Well Segmental resection Day 32 Right phrenic nerve palsy 20 months Well
TABLE 4. Postnatal management and outcome of cases with no symptom at birth
* N/A denotes not applicable
often found in the lower lobe on either side (15 of 20) 
cases. Involvement of more than one lobe was found in 
four cases. There was a slight male predominance in our 
cohort, which was similar to a previous report.14 Eight 
(40%) of our patients presented with a variable degree of 
respiratory distress at birth. Symptoms at birth were re-
ported in around 25 to 44% of other reports.17-19 Hydropic 
change was associated with more severe symptoms and 
poor prognosis.2,15,16,20-25 Earlier reports showed a higher 
incidence of up to 40%,2,14,22 but the figure was lower 
(2-10%) in recent literature.6,15,16,20,26 This complication 
was rarely seen in our cohort. Late complications of 
CCAM include severe or recurrent infection of the lungs 
and malignant change in the lesion. Two of our babies 
presented with infective complications, though they 
were relatively asymptomatic at birth. Overall postnatal 
mortality was reported to be 4 to 37%,15-17,20-24,27 and 
in our series of live births only one of 20 died. There 
have been many studies on the outcome of antenatally 
diagnosed CCAM11,12,15,16,19-27 and various USG features 
have been associated with a poor prognosis, including 
the type and size of CCAM, presence of mediastinal shift 
and hydropic change.2,6,18,20,22-24,27,28 Identification of these 
factors calls for antenatal counselling, possible foetal 
intervention, and preparation of perinatal management 
at tertiary care facilities. In-utero regression was reported 
to occur in 6.3 to 55% of cases (Table 5). This was 
documented in nine (45%) of 20 babies born alive in 
our series and was apparently associated with left-sided 
		#  Congenital	cystic	adenomatoid	malformation	of	the	lung	# 
	 Hong	Kong	Med	J		Vol	13	No	1	# February	2007	#  www.hkmj.org	 37
* TOP denotes termination of pregnancy, SA spontaneous abortion, and IUD intrauterine death
† CXR denotes chest X-ray, CT computed tomography, N/A not available, and N/S not specified
‡ S/m denotes symptomatic after birth, OT operation with resection of the lesion, and NND neonatal death
Studies No. of cases Gestational 
age at 
diagnosis
Ultrasonography 
types of CCAM
Antenatal outcome* Postnatal imaging† Postnatal outcome‡
Present study, 
2003
23 15-33 weeks Macrocystic=7, 
microcystic=6, 
mixed=10
TOP=2, abortion=1, 
hydrops=1, regression=9, 
antenatal shunt=1
7/19 CXR normal, 1/19 
no pulmonary lesions 
on CT
S/m=8/20, death=1/20 (5%), 
OT=15/20 (type I=8, type 
II=6)
Sauvat et al,30 
2003
29 (asympto-
matic at birth)
18-33 weeks N/A TOP=0, regression=12 
(41%), hydrops=0
12 (41%) CXR normal, 
4 (14%) CT normal
OT=17, postnatal regression=6 
(21%), no death
Duncombe et al,15 
2002
21 19-22 weeks Macrocystic=16, 
microcystic=5
TOP=4, hydrops=2 (9.5%), 
regression=4 (19%)
Concurred with
prenatal diagnosis
Death=1/17 (6%), OT=12/17
Laberge et al,16 
2001
48 N/A N/A TOP=7, SA=1, hydrops=1 
(2%), regression=22 (46%)
N/A Death=4/40 (10%)
Monni et al,26 2000 26 19-34 weeks Macrocystic=13, 
microcystic=13
TOP=9, hydrops=2 (8%), 
regression=3 (12%)
Lesions confirmed
clinically/CXR in 11
Death=0/17, decreased size of 
lesion=2/17, OT=9/17
Bunduki et al,20 
2000
18 18-36 weeks Macrocystic=11, 
microcystic=7
TOP=0, IUD=2, hydrops=2 
(11%), regression=3 (17%)
N/A Death=4/16 (25%), OT=13/16
van Leeuwen et 
al,12 1999
16 16-28 weeks Stocker type I=3, 
II=9, III=1, N/A=3
TOP=0, IUD=0, hydrops=0, 
regression=7 (44%)
9/15 CXR negative, CT 
showed lesions in those 
asymptomatic and
negative CXR
Death=0/16, OT=8/16, 
type 1=4/16, type II=2/16, 
pulmonary sequestration=1/16, 
bronchogenic cyst=1/16
Waszak et al,17 
1999
20 (with 
antenatal 
ultrasonogra-
phy among 21 
cases)
21-35 weeks Macrocystic=11, 
microcystic=5, 
N/A=4
TOP=0, hydrops=N/S, 
regression=N/S
3/21 CXR normal, CT 
confirmed diagnosis 
in 15
S/m=5/20, death=0/20, 
OT=18/20 (type I=7, II=10, 
III=1)
Bagolan et al,18 
1999
9 20-36 weeks Macrocystic=3, 
microcystic=6
TOP=0, regression=5 
(56%)
5 regression: 4/5 CXR 
normal, 3/3 CT normal; 
4 non-regression: all 
CXR and CT positive
S/m=4/9, death=0/9, OT=5/9, 
well=9/9
Golaszewski et al,27 
1998
14 18-23 weeks Stocker type I=6, 
II=5, III=3
TOP=4, regression=4 
(29%), hydrops=0
N/S S/m, death=1/10 (10%), 
OT=5/10
Sapin et al,19 1997 18 17-36 weeks N/A Abortion=1, regression= 
5 (28%), static=8, not 
known=4, hydrops=0
All CXR abnormal, CT 
N/S
S/m=6/17, OT=14/17, 
death=0/17, postnatal
regression=3/17
Cacciari et al,4 
1997
16 21-26 weeks N/A TOP=3 (type II), hydrops=1 
(6%), regression=1 (6%)
N/A OT=9, type I=10, type II=3, 
NND=1/13 (8%)
Miller et al,11 1996 17 20-34 weeks Stocker type 
I=12, II=2, III=3
IUD=2, TOP=3, hydrops=4 
(24%), regression=7 (41%)
All had radiological 
evidence of CCAM
OT=12/12
Bromley et al,21 
1995
25 16-37 weeks Stocker type 
I=10, II=5, III=10
IUD=5, hydrops=1 (4%), 
regression=8 (32%)
N/A NND=2/16 (13%), S/m=11/16, 
OT=10/16
Thorpe-Beeston
and Nicolaides,2 
1994
58 17-39 weeks Macrocystic=27, 
microcystic=31
TOP=22/58, IUD=3/58, 
regression=3 (5%),
hydrops=17 (29%),
antenatal shunt=5
N/S NND=3/33 (9%), OT=13/33
Adzick and
Harrison,22 1993
22 20-36 weeks Multicystic=12, 
echogenic=10
TOP=3, hydrops=9 (41%), 
regression=4 (18%)
N/A Death=7/19 (37%), OT=12/19
Dumez et al,23 
1993
18 19-25 weeks Stocker type I=5, 
II=9, III=4
TOP=4, hydrops=3 (17%), 
regression=3 (17%)
N/A Death=1/14 (7%), OT=7/14
Revillon et al,24 
1993
32 16-38 weeks Stocker type 
I=12, II=15, III=5
TOP=5, IUD=1, hydrops=6 
(19%), regression=13 (41%)
N/A Death=1/26 (4%), OT=18/26
 
TABLE 5. Comparison with previous studies on antenatally diagnosed congenital cystic adenomatoid malformation (CCAM)2,4,11,12,15-24,26,27,30
lesions (7/10 cases), microcystic lesions (4/6 cases), and 
disappearance of mediastinal shift (5 cases). Lack of 
histological confirmation remains one of the challenges 
to establishing the incidence and mechanisms of in-utero 
regression. More importantly, in-utero regression noted on 
antenatal USG may not represent ‘genuine’ regression.8,9 
In our series showing such in-utero regression, five were 
diagnosed to have CCAM after birth. In the remaining 
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